Technetium Tc 99m sulfur colloid injection - Pharmalucence

Drug Profile

Technetium Tc 99m sulfur colloid injection - Pharmalucence

Alternative Names: AN-Sulfur Colloid - Pharmalucence; Kit for the preparation of Technetium Tc 99m sulfur colloid injection (SCI) - Pharmalucence; Tc 99m sulfur colloid kit

Latest Information Update: 22 Aug 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmalucence
  • Class Imaging agents; Inorganic sulfur compounds; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Malignant melanoma
  • New Molecular Entity No

Highest Development Phases

  • Marketed Breast cancer; Malignant melanoma

Most Recent Events

  • 16 Aug 2012 Launched for Malignant melanoma (diagnosis; localisation of lymph nodes) in USA (SC)
  • 16 Aug 2012 Registered for Malignant melanoma (diagnosis; localisation of lymph nodes) in USA (SC)
  • 16 Aug 2012 Technetium Tc 99m sulfur colloid injection - Pharmalucence receives Orphan Drug status for Malignant melanoma (localisation of lymph nodes) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top